In a nutshell This study compared treatments for fatty liver disease in patients with type 2 diabetes (T2D). They found that liraglutide (Victoza) reduced liver fat significantly, improved liver function, and led to weight loss and better blood sugar control. Some background Half of the patients with T2D can have liver disease...
Read More
In a nutshell This trial is being carried out to examine the effectiveness of LY3016859 for diabetic neuropathic pain (DNP; pain caused by damage to the nerves). The main outcome to be measured is a change in pain intensity. This study is being carried out in Puerto Rico and the United States. The details Uncontrolled diabetes can lead...
Read More
In a nutshell This study looked at the effect of vitamin D supplements on diabetic neuropathy (DN; nerve damage). They found that taking high-dose vitamin D for 6 months reduced the pain and disability associated with DN. Some background Diabetic neuropathy (DN) refers to nerve damage experienced by diabetic patients. It leads to pain and...
Read More
In a nutshell This study examined the effectiveness and risks of polyethylene glycol loxenatide (PEX168) as an add-on to metformin (Glucophage) therapy in patients with type 2 diabetes (T2D). It found that PEX168 is safe and works effectively in improving the blood sugar levels in these patients. Some background T2D is a...
Read More
In a nutshell This study looked at the effect of weight loss surgery on sexual functioning for men with type 2 diabetes (T2D). It found that fewer men experienced erectile dysfunction (ED) following surgery. Some background T2D is a metabolic disorder in which the body does not respond well to the hormone insulin and cannot create enough insulin to...
Read More
In a nutshell This study compared the effects on heart disease for SGLT2 inhibitors vs DPP-4 inhibitors in patients with type 2 diabetes (T2D). It found that patients using SGLT2 inhibitor medications had lower rates of heart failure, heart attack, and stroke. Some background T2D is a disorder of high levels of glucose (sugar) in the blood. T2D...
Read More
In a nutshell This study looked at adding testosterone undecanoate (Aveed) to standard therapy for men with type 2 diabetes (T2D) and low testosterone levels. It found that men treated with testosterone had better long-term outcomes and that a third of patients achieved remission from diabetes. Some background T2D is a metabolic disorder in which the...
Read More
In a nutshell This review analysis looked at whether psyllium fiber supplements benefit patients with type 2 diabetes (T2D). It found that psyllium improves LDL cholesterol and blood sugar control for patients with T2D. Some background Diabetes is a metabolic condition in which the body cannot reduce high levels of glucose (sugar) in the blood....
Read More
In a nutshell This study looked at how gastric bypass weight-loss surgery affects kidney function for patients with type 2 diabetes, obesity, and early kidney disease. It found that weight-loss surgery improved kidney function more than standard medical care in these patients. Some background Patients with type 2 diabetes (T2D) are at increased risk...
Read More
In a nutshell This study looked at whether iGlarLixi (Soliqua), a combination of long-acting insulin glargine (Lantus) and lixisenatide (Lyxumia), can improve glucose control for patients with type 2 diabetes (T2D) uncontrolled with long-acting insulin alone. It found that iGlarLixi improved overall and after-meal blood sugar control compared to insulin...
Read More
In a nutshell This review looked at whether SGLT2 inhibitors increase the risk of ketoacidosis in patients with type 2 diabetes (T2D). It found that long-term use of these medications increases the risk of ketoacidosis, particularly for older patients. Some background Type 2 diabetes (T2D) is a disorder involving high levels of glucose (sugar) in...
Read More
In a nutshell This study looked at exenatide (Byetta) for patients with type 2 diabetes (T2D) and kidney damage. It found that exenatide may reduce kidney damage compared to other diabetes treatments. Some background T2D is a disorder in which the body does not respond well to the hormone insulin. This causes high levels of glucose (sugar) in the...
Read More
